EpiPenClassAction.com

1-877-221-7632






A Settlement of $345,000,000 has been reached between the Class Plaintiffs and the Pfizer Defendants (which are Pfizer, Inc., Meridian Medical Technologies, Inc., and King Pharmaceuticals LLC (f/k/a King Pharmaceuticals, Inc.)). This Settlement does not concern the resolution of the claims against other defendants in the Action, specifically Mylan N.V., Mylan Specialty L.P., Mylan Pharmaceuticals Inc., Viatris Inc., or Heather Bresch (collectively, the “Mylan Defendants”). Those claims remain pending in the Court and trial of those claims is currently scheduled to commence on January 24, 2022.

The Court has not decided whether Defendants did anything wrong. For additional details and answers to frequently asked questions, please read the Long-Form Notice.

Who is Included?

If you are a person or entity in the United States who paid or provided reimbursement for some or all of the purchase price of Branded or authorized generic EpiPens for the purpose of consumption, and not resale, by yourself, your family member(s), insureds, plan participants, employees, or beneficiaries, at any time between August 24, 2011, and November 1, 2020, and did not exclude yourself from the Class during the initial notice period, you are a Class Member. The exceptions to being included in the Class are detailed in the Settlement Agreement.




Your Rights and Options

SUBMIT A PROOF OF CLAIM

This is the only way to be eligible to receive a payment from the Settlement. Proofs of Claim must be postmarked (if mailed) or received (if submitted online) on or before November 12, 2021.


OBJECT TO THE SETTLEMENT BY SUBMITTING A WRITTEN OBJECTION

Write to the Court and explain why you do not like the Settlement, the Plan of Allocation, and/or the request for attorneys’ fees, expenses, or service awards. Objections must be filed with the Court and received by the parties on or before September 24, 2021.


ATTEND THE FAIRNESS HEARING ON OCTOBER 27, 2021 AT 9:00 A.M. CENTRAL, AND FILE A NOTICE OF INTENTION TO APPEAR

Ask to speak in Court about the fairness of the Settlement. Requests to speak must be filed with the Court and served on the parties on or before September 24, 2021. If you submit a written objection, you may (but you do not have to) attend the hearing.


DO NOTHING

Receive no payment. You will, however, still be a Class Member, which means that you give up your right to ever be part of any other lawsuit against the Pfizer Defendants about the legal claims being resolved by this Settlement and you will be bound by any judgments or orders entered by the Court in the Action.


More Information

This website contains a summary of the Settlement and relevant Court papers. For answers to frequently asked questions, please read the Long-Form Notice. You can also review relevant Decisions and Orders and additional information about this action and the Settlement by accessing the "Court Documents" page of this website. Complete copies of all public pleadings, Court rulings, and other filings are available for review by accessing the Court docket in this case, for a fee, through the Court’s Public Access to Court Electronic Records (PACER) system at https://ecf.ksd.uscourts.gov, or visiting the office of the Clerk of the Court for the United States District Court for the District of Kansas, 500 State Avenue, Kansas City, KS 66101, between 9:00 a.m. and 4:00 p.m., Monday through Friday, excluding Court holidays.